SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-306229
Filing Date
2020-12-01
Accepted
2020-12-01 07:16:02
Documents
14
Period of Report
2020-11-24
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d69549d8k.htm   iXBRL 8-K 27113
2 EX-99.1 d69549dex991.htm EX-99.1 8548
6 GRAPHIC g69549img1.jpg GRAPHIC 7276
  Complete submission text file 0001193125-20-306229.txt   176485

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA acet-20201124.xsd EX-101.SCH 3073
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE acet-20201124_lab.xml EX-101.LAB 18888
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acet-20201124_pre.xml EX-101.PRE 11862
7 EXTRACTED XBRL INSTANCE DOCUMENT d69549d8k_htm.xml XML 3468
Mailing Address 500 BOYLSTON STREET 12TH FLOOR BOSTON MA 02116
Business Address 500 BOYLSTON STREET 12TH FLOOR BOSTON MA 02116 617-482-2333
Adicet Bio, Inc. (Filer) CIK: 0001720580 (see all company filings)

IRS No.: 813305277 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38359 | Film No.: 201359774
SIC: 2834 Pharmaceutical Preparations